Stempeutics Weighs Japan Tie-Up For Stem Cell Therapy
This article was originally published in PharmAsia News
Executive Summary
Japan continues to attract interest in the area of regenerative medicine, with Indian firm Stempeutics Research saying it is eyeing collaboration opportunities for its stem-cell based drug, Stempeucel, initially targeted for the treatment of critical limb ischemia.